These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22840752)

  • 1. Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.
    Yao J; Brinton RD
    Adv Pharmacol; 2012; 64():327-71. PubMed ID: 22840752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease.
    Brinton RD
    Adv Drug Deliv Rev; 2008; 60(13-14):1504-11. PubMed ID: 18647624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications.
    Brinton RD
    Trends Neurosci; 2008 Oct; 31(10):529-37. PubMed ID: 18774188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
    Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
    Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.
    Yao J; Brinton RD
    Curr Pharm Des; 2011; 17(31):3474-9. PubMed ID: 21902662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
    Yao J; Chen S; Mao Z; Cadenas E; Brinton RD
    PLoS One; 2011; 6(7):e21788. PubMed ID: 21747957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen: a master regulator of bioenergetic systems in the brain and body.
    Rettberg JR; Yao J; Brinton RD
    Front Neuroendocrinol; 2014 Jan; 35(1):8-30. PubMed ID: 23994581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer's Mouse Model.
    Wang T; Yao J; Chen S; Mao Z; Brinton RD
    Neurotherapeutics; 2020 Jan; 17(1):178-188. PubMed ID: 31664643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria as therapeutic targets of estrogen action in the central nervous system.
    Nilsen J; Brinton RD
    Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):297-313. PubMed ID: 15379606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
    Sotolongo K; Ghiso J; Rostagno A
    Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer's Disease by Preserving Mitochondrial Function in APP/PS1 Mice and Neurons.
    Zhao FL; Fang F; Qiao PF; Yan N; Gao D; Yan Y
    Oxid Med Cell Longev; 2016; 2016():8360738. PubMed ID: 27057285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.
    Fleck D; Phu L; Verschueren E; Hinkle T; Reichelt M; Bhangale T; Haley B; Wang Y; Graham R; Kirkpatrick DS; Sheng M; Bingol B
    J Neurosci; 2019 Jun; 39(24):4636-4656. PubMed ID: 30948477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.
    Ferrer I
    J Bioenerg Biomembr; 2009 Oct; 41(5):425-31. PubMed ID: 19798558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer's disease.
    Poirier Y; Grimm A; Schmitt K; Eckert A
    Cell Mol Life Sci; 2019 Apr; 76(7):1419-1431. PubMed ID: 30683981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis.
    Liao TL; Tzeng CR; Yu CL; Wang YP; Kao SH
    Ann N Y Acad Sci; 2015 Sep; 1350():52-60. PubMed ID: 26301952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium Signaling and Mitochondrial Function in Presenilin 2 Knock-Out Mice: Looking for Any Loss-of-Function Phenotype Related to Alzheimer's Disease.
    Rossi A; Galla L; Gomiero C; Zentilin L; Giacca M; Giorgio V; Calì T; Pozzan T; Greotti E; Pizzo P
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.